Global Anticoagulants Market to Spike to Over $24 Billion by 2019
(firmenpresse) - NEW YORK, NY -- (Marketwire) -- 03/11/13 -- TriMarkPublications.com cites in its newly published "New Oral Markets" report that the global market will spike to over $24 billion by 2019. For more information, visit: .
can be categorized into five main modalities: low molecular weight heparins (LMWHs), herapins, warfarin, direct thrombin inhibitors (DTIs) and factor Xa inhibitors. The U.S. market, which encompasses over 60% of the global market for , will grow from $7.06 billion in 2012 to $15.32 billion in 2019 as it shifts from being monopolized by a single injectable , warfarin, to once-daily oral .
The "New Oral Markets" report covers:
Dabigatran (Pradaxa)
Rivaroxaban (Xarelto)
Eliquis (Apixaban)
Edoxaban
Betrixaban
Antiplatelets
Clotting Assays
Cardiovascular Diseases
Cardiac Arrhythmia
Coronary Artery Disease
Myocardial Infarction
Heart Valve Replacement
Deep Vein Thrombosis (DVT)
The "New Oral Markets" report examines companies manufacturing equipment and supplies in the world. Companies covered include: Akers, Anthera, ARYx, AstraZeneca, Boehringer Ingelheim, Cipla, Daiichi Sankyo, Eisai, Eli Lilly, Genentech, GlaxoSmithKline, Medicines Company, Medicure, Merck, Novartis, Ortho-McNeil, Pfizer, Pharmion, Portola and Sanofi.
Detailed charts with sales forecasts and marketshare data are included. For more information, visit: .
TriMarkPublications.com is a global leader in the biotechnology, healthcare and life sciences market research publishing. For more information, please visit .
The statements contained in this news release that are forward-looking are based on current expectations that are subject to a number of uncertainties and risks, and actual results may differ materially.
TriMarkPublications.com
Media Relations
1-888-OK-TRIMARK
Themen in dieser Pressemitteilung:
Unternehmensinformation / Kurzprofil:
Datum: 11.03.2013 - 16:30 Uhr
Sprache: Deutsch
News-ID 238096
Anzahl Zeichen: 0
contact information:
Town:
NEW YORK, NY
Kategorie:
Commercial & Investment Banking
Diese Pressemitteilung wurde bisher 204 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Global Anticoagulants Market to Spike to Over $24 Billion by 2019"
steht unter der journalistisch-redaktionellen Verantwortung von
TriMarkPublications.com (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
